Formula Growth’s Palantir PLTR Stock Holding History

Formula Growth’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,916	Closed	-$599K	–	148
2021 Q4	$599K	Hold	32,916	–	–	0.11%	130
2021 Q3	$791K	Hold	32,916	–	–	0.11%	135
2021 Q2	$868K	Hold	32,916	–	–	0.12%	136
2021 Q1	$767K	Sell	32,916 -10,000	-23%	-$274K	0.11%	150
2020 Q4	$1.01M	Sell	42,916 -215,084	-83%	-$3.85M	0.17%	123
2020 Q3	$2.45M	Buy	+258,000	New	+$2.45M	0.46%	58

Other funds holding PLTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Formula Growth's PLTR Position: Q1 2022 in Review

Formula Growth sold out of Palantir (PLTR) in Q1 2022, closing a stake of 32,916 shares — an estimated $599K sold.

Formula Growth first reported a position in PLTR in Q3 2020 and held it in 6 quarters. The position peaked at $2.45M in Q3 2020. 829 funds tracked by Wall St. Rank hold PLTR as of Q1 2022.

Formula Growth reported no remaining Palantir position as of Q1 2022 after selling out during the quarter.
Formula Growth sold 32,916 Palantir shares in Q1 2022, an estimated $599K.
Formula Growth first reported a position in Palantir in Q3 2020 and held it in 6 quarters.
Formula Growth's Palantir position peaked at $2.45M in Q3 2020.
829 funds tracked by Wall St. Rank held Palantir as of Q1 2022.

Based on Formula Growth's 13F filing for Q1 2022, filed 13 May 2022.